← All trials
NCT00607217
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2008
- Primary completion
- Sep 30, 2008
- Completion date
- Sep 30, 2008
- First posted
- Feb 5, 2008
- Last posted
- Jan 22, 2009
- Enrollment
- 360
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Shahid Beheshti University of Medical SciencesLead sponsor
- Tehran University of Medical ScienceSponsor investigator
- Shahid Beheshti University of Medical SciencesOverall official - principal investigator
- Shahid Beheshti University of Medical SciencesOfficial
- Shahid Beheshti University of Medical SciencesOfficial
- Shahid Beheshti University of Medical SciencesOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.